Jazz Pharmaceuticals price target lowered to $195 from $200 at TD Cowen
The Fly

Jazz Pharmaceuticals price target lowered to $195 from $200 at TD Cowen

TD Cowen lowered the firm’s price target on Jazz Pharmaceuticals (JAZZ) to $195 from $200 and keeps a Buy rating on the shares. The firm said total Q3 revenue came above expectations supported by beats from Xywav Epidiolex Defitelio and Zepzelca.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App